TIMOLOL AND NASOLACRIMAL DUCT OBSTRUCTION


EyeWorld Magazine: February 2008:

According to this report:

“Chronic use of timolol-containing topical glaucoma therapy preparations in glaucoma patients is associated with an increased risk for the development of nasolacrimal duct obstruction.”

Comments

Popular posts from this blog

Keratoconus and Inflammatory Skin Conditions

CORNEA CROSS-LINKING RE-TREATMENT

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS